{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:39:04Z","timestamp":1780364344111,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":336,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"publisher","award":["MPG16-7"],"award-info":[{"award-number":["MPG16-7"]}],"id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ctarc.2024.100856","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T11:44:11Z","timestamp":1733139851000},"page":"100856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma"],"prefix":"10.1016","volume":"42","author":[{"given":"Andrew C.","family":"Kidd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon W.","family":"Cowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Evison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-6641","authenticated-orcid":false,"given":"Kevin G.","family":"Blyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ctarc.2024.100856_bib0001","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100856_bib0002","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/JTO.0b013e31817c73d6","article-title":"Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemona\u00efve patients with malignant pleural mesothelioma: results of the International Expanded Access Program","volume":"3","author":"Santoro","year":"2008","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2024.100856_bib0003","unstructured":"Consortium SM. nivolumab (Opdivo\u00ae) is accepted for use within NHS Scotland.: Scottish Medicines Consortium; 2022 [cited 2022 26\/02\/22]. https:\/\/www.scottishmedicines.org.uk\/medicines-advice\/nivolumab-opdivo-full-smc2385\/]."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100856_bib0004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiol.2021210576","article-title":"Association of Adipopenia at Preoperative PET\/CT with Mortality in Stage I Non\u2013Small Cell Lung Cancer","volume":"301","author":"Choi","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0005","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.jss.2011.04.061","article-title":"Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival","volume":"170","author":"Yang","year":"2011","journal-title":"J. Surg. Res."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100856_bib0006","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100856_bib0007","first-page":"1699","article-title":"Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer","volume":"23","author":"Kimura","year":"2015","journal-title":"Support. Care Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0008","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/diagnostics12010099","article-title":"Sarcopenia, Precardial Adipose Tissue and High Tumor Volume as Outcome Predictors in Surgically Treated Pleural Mesothelioma","volume":"12","author":"Verhoek","year":"2022","journal-title":"Diagnostics"},{"issue":"15","key":"10.1016\/j.ctarc.2024.100856_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153699","article-title":"Sarcopenia as a Predictor of Short- and Long-Term Outcomes in Patients Surgically Treated for Malignant Pleural Mesothelioma","volume":"14","author":"Faccioli","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"10","key":"10.1016\/j.ctarc.2024.100856_bib0010","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41430-019-0418-9","article-title":"Body composition and nutritional status in malignant pleural mesothelioma: implications for activity levels and quality of life","volume":"73","author":"Jeffery","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ctarc.2024.100856_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41430-021-01062-6","article-title":"Changes in body composition in patients with malignant pleural mesothelioma and the relationship with activity levels and dietary intake","author":"Jeffery","year":"2022","journal-title":"Eur. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.ctarc.2024.100856_bib0012","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100856_bib0013","doi-asserted-by":"crossref","first-page":"543","DOI":"10.21037\/tlcr.2018.07.05","article-title":"The eighth TNM classification for malignant pleural mesothelioma","volume":"7","author":"Berzenji","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100856_bib0014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body Mass Index: Obesity, BMI, and Health: A Critical Review","volume":"50","author":"Nuttall","year":"2015","journal-title":"Nutr. Today"},{"key":"10.1016\/j.ctarc.2024.100856_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2021-217808","article-title":"Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria","author":"Kidd","year":"2022","journal-title":"Thorax."},{"issue":"2","key":"10.1016\/j.ctarc.2024.100856_bib0016","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0017","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100856_bib0018","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2017-000240","article-title":"Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors","volume":"5","author":"Kidd","year":"2018","journal-title":"BMJ Open. Respir. Res."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000506","article-title":"Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics","volume":"8","author":"Gunatilake","year":"2021","journal-title":"BMJ Open. Respir. Res."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100856_bib0021","first-page":"1871","article-title":"A cross-sectional study examining the prevalence of cachexia and areas of unmet need in patients with cancer","volume":"26","author":"Vagnildhaug","year":"2018","journal-title":"Support. Care Cancer"},{"issue":"7","key":"10.1016\/j.ctarc.2024.100856_bib0022","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/01635581.2015.1073753","article-title":"An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status","volume":"67","author":"Sun","year":"2015","journal-title":"Nutr. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2024.100856_bib0023","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.cllc.2016.09.008","article-title":"Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer","volume":"18","author":"Sj\u00f8blom","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2024.100856_bib0024","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4187\/respcare.02848","article-title":"Physical activity impairment in depressed COPD subjects","volume":"59","author":"Di Marco","year":"2014","journal-title":"Respir. Care"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100856_bib0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/0284186X.2014.953259","article-title":"Changes in skeletal muscle mass during palliative chemotherapy in patients with advanced lung cancer","volume":"54","author":"Stene","year":"2015","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11864-019-0691-9","article-title":"Chemotherapy-Induced Sarcopenia","volume":"21","author":"Bozzetti","year":"2020","journal-title":"Curr. Treat. Options. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0027","doi-asserted-by":"crossref","first-page":"86","DOI":"10.21037\/apm.2018.08.02","article-title":"Sarcopenia associated with chemotherapy and targeted agents for cancer therapy","volume":"8","author":"Davis","year":"2018","journal-title":"Ann. Palliative Med."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100856_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041242","article-title":"Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies","volume":"21","author":"Conte","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100856_bib0029","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jcsm.12795","article-title":"Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice","volume":"12","author":"Hain","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/1055-9965.EPI-16-0439","article-title":"The Obesity Paradox in Cancer-Moving Beyond BMI","volume":"26","author":"Strulov Shachar","year":"2017","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.ctarc.2024.100856_bib0031","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2022.09.011","article-title":"High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer","volume":"167","author":"Buckley","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ctarc.2024.100856_bib0032","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2016.04.018","article-title":"Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma \u2013 A multi-institutional study","volume":"63","author":"Hoda","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0033","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1038\/s41598-017-16551-7","article-title":"Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma","volume":"7","author":"Klikovits","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ctarc.2024.100856_bib0034","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/09537104.2016.1246712","article-title":"Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis","volume":"28","author":"Zhuo","year":"2017","journal-title":"Platelets."},{"issue":"10","key":"10.1016\/j.ctarc.2024.100856_bib0035","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/oby.22294","article-title":"Associations of Platelet Indices with Body Fat Mass and Fat Distribution","volume":"26","author":"Han","year":"2018","journal-title":"Obesity. (Silver. Spring)"},{"issue":"9","key":"10.1016\/j.ctarc.2024.100856_bib0036","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014740","article-title":"Relationship between inflammatory markers and visceral obesity in obese and overweight Korean adults: An observational study","volume":"98","author":"Yu","year":"2019","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100856_bib0037","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100856_bib0038","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial","volume":"8","author":"Solheim","year":"2018","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.ctarc.2024.100856_bib0039","doi-asserted-by":"crossref","first-page":"S1177","DOI":"10.1016\/j.annonc.2021.08.1650","article-title":"1678P The effect of resistance training in breast cancer patients with sarcopenia during chemotherapy","volume":"32","author":"Kurniawan","year":"2021","journal-title":"Ann. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:10:55Z","timestamp":1778893855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294224000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":39,"alternative-id":["S2468294224000686"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100856","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100856"}}